Nanotechnology for cancer diagnosis and treatment.

Cancer remains the second most common cause of death in the EU despite recent significant advances. The development of more effective targeted therapies could dramatically improve the way we treat the disease.

Health

© Thinkstock

Keywords

Pancreatic cancer, modular nanosystems platform, MMP, siRNA, PLK-1

Project Information

SAVEME

Grant agreement ID: 263307

Project closed

Start date 1 March 2011

End date 28 February 2015

Funded under

• Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies

Total cost € 13 809 085,64

EU contribution € 10 500 000,00

Coordinated by

TEL AVIV UNIVERSITY
Israel